Connecting you to content on EBSCOhost

Works by Wieland, Anja

Results: 5

1

Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 7, p. 1581, doi. 10.1007/s00432-016-2161-0

By:

Schäfer, Niklas;
Gielen, Gerrit;
Kebir, Sied;
Wieland, Anja;
Till, Andreas;
Mack, Frederic;
Schaub, Christina;
Tzaridis, Theophilos;
Reinartz, Roman;
Niessen, Michael;
Fimmers, Rolf;
Simon, Matthias;
Coch, Christoph;
Fuhrmann, Christine;
Herrlinger, Ulrich;
Scheffler, Björn;
Glas, Martin

Publication type:

Article

2

L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.

Published in:

Carcinogenesis, 2011, v. 32, n. 3, p. 262, doi. 10.1093/carcin/bgq249

By:

Doberstein, Kai;
Wieland, Anja;
Lee, Sophia B. Boyoung;
Blaheta, Roman A. Alexander;
Wedel, Steffen;
Moch, Holger;
Schraml, Peter;
Pfeilschifter, Josef;
Kristiansen, Glen;
Gutwein, Paul

Publication type:

Article

3

PAX2 Regulates ADAM10 Expression and Mediates Anchorage-Independent Cell Growth of Melanoma Cells.

Published in:

PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0022312

By:

Sophia Boyoung Lee;
Doberstein, Kai;
Baumgarten, Peter;
Wieland, Anja;
Ungerer, Christopher;
Bü rger, Claudia;
Hardt, Katja;
Boehncke, Wolf-Henning;
Pfeilschifter, Josef;
Mihic-Probst, Daniela;
Mittelbronn, Michel;
Gutwein, Paul

Publication type:

Article

4

Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45535-1

By:

Rösing, Sarah;
Ullrich, Fabian;
Meisterfeld, Susann;
Schmidt, Franziska;
Mlitzko, Laura;
Croon, Marijana;
Nattrass, Ryan G;
Eberl, Nadia;
Mahlberg, Julia;
Schlee, Martin;
Wieland, Anja;
Simon, Philipp;
Hilbig, Daniel;
Reuner, Ulrike;
Rapp, Alexander;
Bremser, Julia;
Mirtschink, Peter;
Drukewitz, Stephan;
Zillinger, Thomas;
Beissert, Stefan

Publication type:

Article

5

Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in Glioblastoma.

Published in:

Stem Cells, 2013, v. 31, n. 6, p. 1064, doi. 10.1002/stem.1350

By:

Glas, Martin;
Coch, Christoph;
Trageser, Daniel;
Daßler, Juliane;
Simon, Matthias;
Koch, Philipp;
Mertens, Jerome;
Quandel, Tamara;
Gorris, Raphaela;
Reinartz, Roman;
Wieland, Anja;
Von Lehe, Marec;
Pusch, Annette;
Roy, Kristin;
Schlee, Martin;
Neumann, Harald;
Fimmers, Rolf;
Herrlinger, Ulrich;
Brüstle, Oliver;
Hartmann, Gunther

Publication type:

Article